Cargando…

Different Approaches to Analyze Muscle Fat Replacement With Dixon MRI in Pompe Disease

Quantitative MRI is an increasingly used method to monitor disease progression in muscular disorders due to its ability to measure changes in muscle fat content (reported as fat fraction) over a short period. Being able to objectively measure such changes is crucial for the development of new treatm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alonso-Jiménez, Alicia, Nuñez-Peralta, Claudia, Montesinos, Paula, Alonso-Pérez, Jorge, García, Carme, Montiel, Elena, Belmonte, Izaskun, Pedrosa, Irene, Segovia, Sonia, Llauger, Jaume, Díaz-Manera, Jordi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298190/ https://www.ncbi.nlm.nih.gov/pubmed/34305788 http://dx.doi.org/10.3389/fneur.2021.675781

Ejemplares similares

Follow‐up of late‐onset Pompe disease patients with muscle magnetic resonance imaging reveals increase in fat replacement in skeletal muscles
por: Nuñez‐Peralta, Claudia, et al.
Publicado: (2020)

Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study
por: Figueroa-Bonaparte, Sebastian, et al.
Publicado: (2018)

Magnetization Transfer Ratio in Lower Limbs of Late Onset Pompe Patients Correlates With Intramuscular Fat Fraction and Muscle Function Tests
por: Nuñez-Peralta, Claudia, et al.
Publicado: (2021)

Corrigendum: Magnetization Transfer Ratio in Lower Limbs of Late Onset Pompe Patients Correlates With Intramuscular Fat Fraction and Muscle Function Tests
por: Nuñez-Peralta, Claudia, et al.
Publicado: (2021)

Correlation Between Respiratory Accessory Muscles and Diaphragm Pillars MRI and Pulmonary Function Test in Late-Onset Pompe Disease Patients
por: Reyes-Leiva, David, et al.
Publicado: (2021)

PDGF-BB serum levels are decreased in adult onset Pompe patients
por: Fernández-Simón, Esther, et al.
Publicado: (2019)

Identification of serum microRNAs as potential biomarkers in Pompe disease
por: Carrasco‐Rozas, Ana, et al.
Publicado: (2019)

Muscle MRI Findings in Childhood/Adult Onset Pompe Disease Correlate with Muscle Function
por: Figueroa-Bonaparte, Sebastián, et al.
Publicado: (2016)

Platelet Derived Growth Factor-AA Correlates With Muscle Function Tests and Quantitative Muscle Magnetic Resonance in Dystrophinopathies
por: Alonso-Jiménez, Alicia, et al.
Publicado: (2021)

MON-LB073 The Serum Creatinine to Serum Cystatin C Ratio Is a Reliable Surrogate Marker of Sarcopenia in Patients with Cushing's Syndrome in Remission
por: Martel, Luciana, et al.
Publicado: (2019)

MON-LB074 Ultrasonography May Reliably Assess Muscle Architecture in Patients with Cushing's Syndrome in Remission: Comparison with Gold-Standard Muscle MRI
por: Martel, Luciana, et al.
Publicado: (2019)

Muscle MRI in muscular dystrophies
por: Díaz-Manera, Jordi, et al.
Publicado: (2015)

Water–fat Dixon cardiac magnetic resonance fingerprinting
por: Jaubert, Olivier, et al.
Publicado: (2019)

STIG study: real-world data of long-term outcomes of adults with Pompe disease under enzyme replacement therapy with alglucosidase alfa
por: Gutschmidt, Kristina, et al.
Publicado: (2021)

The Dixon method in musculoskeletal MRI: from fat-sensitive to fat-specific imaging
por: Omoumi, Patrick
Publicado: (2021)

Quantification of epicardial fat using 3D cine Dixon MRI
por: Henningsson, Markus, et al.
Publicado: (2020)

Therapeutic Options for the Management of Pompe Disease: Current Challenges and Clinical Evidence in Therapeutics and Clinical Risk Management
por: Bolano-Diaz, Carla, et al.
Publicado: (2022)

Professor Geoffrey Dixon
Publicado: (1980)

Allan Dixon Mitchell
Publicado: (1913)

John Dixon Comrie
Publicado: (1939)

The Dixon-Jones Case
Publicado: (1890)

Enzyme replacement therapy (ERT) in pompe disease
por: Fiumara, Agata
Publicado: (2014)

Survey on the management of Pompe disease in routine clinical practice in Spain
por: Domínguez-González, Cristina, et al.
Publicado: (2022)

Myocardial fat quantification using 2D Dixon MRI: feasibility study
por: Liu, Chia-Ying, et al.
Publicado: (2009)

Artifact-free fat-water separation in Dixon MRI using deep learning
por: Basty, Nicolas, et al.
Publicado: (2023)

Enzyme replacement therapy and fatigue in adults with Pompe disease
por: Güngör, Deniz, et al.
Publicado: (2013)

Charles J. W. Dixon
por: Hogben, John
Publicado: (1926)

Dr. Franklin Morris Dixon
Publicado: (1893)

Impact of enzyme replacement therapy on survival in adults with Pompe disease
por: Güngör, Deniz, et al.
Publicado: (2013)

Enzyme replacement therapy and antibodies in late-onset Pompe disease
por: Schneider, I., et al.
Publicado: (2014)

Impact of incorrect tissue classification in Dixon-based MR-AC: fat-water tissue inversion
por: Ladefoged, Claes Nøhr, et al.
Publicado: (2014)

Comparison of pancreatic fat content measured by different methods employing MR mDixon sequence
por: Li, Xiaoyang, et al.
Publicado: (2021)

Application of multi-echo Dixon and MRS in quantifying hepatic fat content and staging liver fibrosis
por: Jiang, Yanli, et al.
Publicado: (2023)

Death of Dr. J. Dixon Mann
Publicado: (1912)

Two-point Dixon and six-point Dixon magnetic resonance techniques in the detection, quantification and grading of hepatic steatosis
por: Elfaal, Mohamed, et al.
Publicado: (2023)

S2.2 Enzyme replacement therapy in the infantile-onset Pompe disease
por: Parenti, Giancarlo, et al.
Publicado: (2011)

Teaching tolerance: New approaches to enzyme replacement therapy for Pompe disease
por: Cousens, Leslie P., et al.
Publicado: (2012)

Enzyme Replacement Therapy Can Reverse Pathogenic Cascade in Pompe Disease
por: Meena, Naresh Kumar, et al.
Publicado: (2020)

The impact of interrupting enzyme replacement therapy in late-onset Pompe disease
por: Wenninger, Stephan, et al.
Publicado: (2021)

Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease
por: Tarallo, Antonietta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jq95uqen2gfq8ka2c2ss42m2bq